Organization (Hospital)
MEDSTAR HEALTH, INC.
ClinicalTrials.gov lists MEDSTAR HEALTH, INC. as lead sponsor of 162 trials, counting the companies grouped under it. MEDSTAR HEALTH, INC. itself has 1 active development program.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers MEDSTAR HEALTH, INC. and 2 companies grouped under it: 162 lead-sponsored trials (1 its own, 161 in the grouped companies) and 5 legal-entity registrations (2 its own, 3 in the grouped companies).
Companies grouped under this page (2)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| MedStar Health Research Institute | 160 | 2 |
| MedStar Georgetown University Hospital | 1 | 1 |
Disease areas (181)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 15 |
| Pain | 15 |
| Coronary Disease | 13 |
| Coronary Artery Disease | 9 |
| Stroke | 9 |
Showing 5 of 181 disease areas.
Trials by start year as sponsor or collaborator (6)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2024 | 2 |
| 2023 | 1 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 1 |
| 2016 | 1 |
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (1)
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| VX-765 | COVID-19 | Phase 2 | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 1 hit target (n=1) | 0 of 1 on time (n=1) |
Journals published in (316)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Obstetrics and gynecology | 23 |
| Cardiovascular revascularization medicine : including molecular interventions | 14 |
| The New England journal of medicine | 13 |
| JAMA | 10 |
| Journal of the American College of Cardiology | 9 |
Showing 5 of 316 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 25 | 12 | 2025-12-02 |
Financing and grant events (69)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-30 | NIH grant | 380,811 | Reporter |
| 2025-09-24 | NIH grant | 999,967 | Reporter |
| 2025-08-18 | NIH grant | 675,867 | Reporter |
| 2025-08-11 | NIH grant | 702,779 | Reporter |
| 2025-05-22 | NIH grant | 403,383 | Reporter |
Showing 5 of 69 events.
Organization relationships (39)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Georgetown University | Co sponsors trial with | 6 |
| Children's National Research Institute | Co sponsors trial with | 5 |
| Government of the United States of America | Co sponsors trial with | 4 |
| University System of Maryland | Co sponsors trial with | 3 |
| Ohio State University | Co sponsors trial with | 3 |
Showing 5 of 39 relationships.
Latest dated events (333)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-01-04 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-11-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09-17 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 333 events.
Biomarker capability evidence (23)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| EPCAM | Trial collaborator | Named in trial inclusion criteria |
| MLH1 | Trial collaborator | Named in trial inclusion criteria |
| MSH2 | Trial collaborator | Named in trial inclusion criteria |
| MSH6 | Trial collaborator | Named in trial inclusion criteria |
| PMS2 | Trial collaborator | Named in trial inclusion criteria |
Showing 5 of 23 evidence rows.
Biomarkers this organization publishes on (519)
Shown in this order: most publications first.
Showing 5 of 519 biomarkers.
On Scientist.com
MEDSTAR HEALTH, INC. is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with MedStar Health Research Institute on Scientist.com
For prices, more details, or to contact MedStar Health Research Institute, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.